Every dollar your 340B program earns should help expand patient care.
Many covered entities lose 30–40% of their 340B revenue to contract pharmacy and third-party administrator (TPA) fees before the funds reach their organization. For safety-net providers with tight margins, that revenue could support additional staff, expand services, new equipment, and improved patient care.
Provider office dispensing delivers superior patient experience and more efficient care.
Increase 340B Revenue with Provider Office Dispensing
By dispensing eligible medications directly at the point of care, healthcare organizations can eliminate many contract pharmacy dispensing fees, simplify administration, and retain up to 88% of their 340B revenue.
The advantages extend beyond financial performance. Patients leave their appointment with medication in hand, which reduces delays in starting therapy, improves medication adherence, and eliminates an extra trip to the pharmacy.
As the 340B landscape continues to evolve, more covered entities are evaluating whether traditional contract pharmacy arrangements still deliver sufficient value. For many organizations, provider office dispensing has become a more effective strategy because it improves patient care while allowing them to keep more revenue.
If your organization is losing 30–40% of its 340B revenue to outside fees, now is the time to explore a model that helps you retain more of your 340B savings. Contact RxFusion today or request a free provider office dispensing analysis to learn how we can help.